Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2025
    • ACR Convergence 2025
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2025
    • ACR Convergence 2025
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023

Index by author

February 01, 2026; Volume 93,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Abdelmalak, Basem B.

    1. You have access
      Suzetrigine: A novel nonopioid systemic analgesic
      Anthony E. Divito, MD, Matthew Sharobeem, DO, Gausan R. Bajracharya, MD and Basem B. Abdelmalak, MD
      Cleveland Clinic Journal of Medicine February 2026, 93 (2) 94-98; DOI: https://doi.org/10.3949/ccjm.93a.25087

      The systemic sodium channel blocker suzetrigine may serve as another option for multimodal postoperative analgesia regimens and for managing acute nonsurgical pain.

  2. Agrwal, Neera

    1. You have access
      Should potassium-competitive acid blockers replace proton pump inhibitors as first-line therapy for patients with severe (Los Angeles grade C or D) esophagitis?
      Sandra Elmasry, MD, Allon Kahn, MD, Lisa Marks, MLS, AHIP and Neera Agrwal, MD, PhD
      Cleveland Clinic Journal of Medicine February 2026, 93 (2) 84-87; DOI: https://doi.org/10.3949/ccjm.93a.25044

      Potassium-competitive acid blockers are reserved for patients who cannot tolerate proton pump inhibitors or who do not respond to them.

  3. Anwer, Faiz

    1. You have access
      Rapidly progressive kidney failure in an 82-year-old man with respiratory symptoms
      CME article
      Bernardo Henrique Mendes Correa, MD, Ali Mushtaq, MD, Ali Awada, Faiz Anwer, MD and Anam Ashfaque, MD
      Cleveland Clinic Journal of Medicine February 2026, 93 (2) 99-105; DOI: https://doi.org/10.3949/ccjm.93a.25037

      The patient presented to the emergency department due to worsening dry cough, lower-extremity edema, and fatigue, all of which had begun about 2 weeks earlier.

  4. Ashfaque, Anam

    1. You have access
      Rapidly progressive kidney failure in an 82-year-old man with respiratory symptoms
      CME article
      Bernardo Henrique Mendes Correa, MD, Ali Mushtaq, MD, Ali Awada, Faiz Anwer, MD and Anam Ashfaque, MD
      Cleveland Clinic Journal of Medicine February 2026, 93 (2) 99-105; DOI: https://doi.org/10.3949/ccjm.93a.25037

      The patient presented to the emergency department due to worsening dry cough, lower-extremity edema, and fatigue, all of which had begun about 2 weeks earlier.

  5. Awada, Ali

    1. You have access
      Rapidly progressive kidney failure in an 82-year-old man with respiratory symptoms
      CME article
      Bernardo Henrique Mendes Correa, MD, Ali Mushtaq, MD, Ali Awada, Faiz Anwer, MD and Anam Ashfaque, MD
      Cleveland Clinic Journal of Medicine February 2026, 93 (2) 99-105; DOI: https://doi.org/10.3949/ccjm.93a.25037

      The patient presented to the emergency department due to worsening dry cough, lower-extremity edema, and fatigue, all of which had begun about 2 weeks earlier.

  6. Bajracharya, Gausan R.

    1. You have access
      Suzetrigine: A novel nonopioid systemic analgesic
      Anthony E. Divito, MD, Matthew Sharobeem, DO, Gausan R. Bajracharya, MD and Basem B. Abdelmalak, MD
      Cleveland Clinic Journal of Medicine February 2026, 93 (2) 94-98; DOI: https://doi.org/10.3949/ccjm.93a.25087

      The systemic sodium channel blocker suzetrigine may serve as another option for multimodal postoperative analgesia regimens and for managing acute nonsurgical pain.

  7. Correa, Bernardo Henrique Mendes

    1. You have access
      Rapidly progressive kidney failure in an 82-year-old man with respiratory symptoms
      CME article
      Bernardo Henrique Mendes Correa, MD, Ali Mushtaq, MD, Ali Awada, Faiz Anwer, MD and Anam Ashfaque, MD
      Cleveland Clinic Journal of Medicine February 2026, 93 (2) 99-105; DOI: https://doi.org/10.3949/ccjm.93a.25037

      The patient presented to the emergency department due to worsening dry cough, lower-extremity edema, and fatigue, all of which had begun about 2 weeks earlier.

  8. Divito, Anthony E.

    1. You have access
      Suzetrigine: A novel nonopioid systemic analgesic
      Anthony E. Divito, MD, Matthew Sharobeem, DO, Gausan R. Bajracharya, MD and Basem B. Abdelmalak, MD
      Cleveland Clinic Journal of Medicine February 2026, 93 (2) 94-98; DOI: https://doi.org/10.3949/ccjm.93a.25087

      The systemic sodium channel blocker suzetrigine may serve as another option for multimodal postoperative analgesia regimens and for managing acute nonsurgical pain.

  9. Elmasry, Sandra

    1. You have access
      Should potassium-competitive acid blockers replace proton pump inhibitors as first-line therapy for patients with severe (Los Angeles grade C or D) esophagitis?
      Sandra Elmasry, MD, Allon Kahn, MD, Lisa Marks, MLS, AHIP and Neera Agrwal, MD, PhD
      Cleveland Clinic Journal of Medicine February 2026, 93 (2) 84-87; DOI: https://doi.org/10.3949/ccjm.93a.25044

      Potassium-competitive acid blockers are reserved for patients who cannot tolerate proton pump inhibitors or who do not respond to them.

  10. Kahn, Allon

    1. You have access
      Should potassium-competitive acid blockers replace proton pump inhibitors as first-line therapy for patients with severe (Los Angeles grade C or D) esophagitis?
      Sandra Elmasry, MD, Allon Kahn, MD, Lisa Marks, MLS, AHIP and Neera Agrwal, MD, PhD
      Cleveland Clinic Journal of Medicine February 2026, 93 (2) 84-87; DOI: https://doi.org/10.3949/ccjm.93a.25044

      Potassium-competitive acid blockers are reserved for patients who cannot tolerate proton pump inhibitors or who do not respond to them.

« Previous (Pages : 1 2 3 ... 3) Next »
Back to top
Previous

In this issue

Cleveland Clinic Journal of Medicine: 93 (2)
Cleveland Clinic Journal of Medicine
Vol. 93, Issue 2
1 Feb 2026
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Artificial intelligence in medicine: How it works, how it fails
  • Rapidly progressive kidney failure in an 82-year-old man with respiratory symptoms
  • Preventing cirrhosis: Why primary care clinicians should screen for liver disease in patients who drink heavily
Sign up for alerts
  • Editor's Picks
  • Most Cited
  • Most Read
Loading
  • Meta-analysis: Its strengths and limitations
  • Primary angiitis of the central nervous system: diagnostic criteria and clinical approach
  • The essential role of exercise in the management of type 2 diabetes
  • Role of uric acid in hypertension, renal disease, and metabolic syndrome
  • Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey
More...

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2026 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire